Harnessing Advanced Biologics to Enhance Bone Regeneration and Implant Success

By
George A. Mandelaris
September 1, 2026
3 min

Compendium

Background

The integration of advanced biologics in implant dentistry is crucial for improving patient outcomes in bone regeneration. The evolution of biologics and growth factor technologies has expanded treatment options for patients requiring bone reconstruction.

Data Highlights

No numerical data provided in the source material.

Key Findings

INDUCE Oi-9® enhances regeneration outcomes, appearing similar to native bone upon re-entry.
The proprietary NMP® processing protocol increases the bioavailability of multiple native growth factors.
INDUCE Oi-9® is associated with improved bone quality and quantity while minimizing postoperative edema.
The material is versatile and easy to use across various regenerative procedures.
It has a 5-year shelf-life and can be stored at room temperature, streamlining inventory management.

Clinical Implications

Clinicians may consider incorporating INDUCE Oi-9® into their regenerative protocols to enhance bone regeneration outcomes. The material's favorable handling characteristics and storage convenience may also facilitate its use in diverse clinical settings.

Conclusion

The advancements in biologics, particularly INDUCE Oi-9®, represent significant progress in the field of regenerative dentistry, contributing to more predictable treatment outcomes.